Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

BACKGROUND: Persons with an opioid use disorder (OUD) who were incarcerated face many challenges to remaining abstinent; concomitantly, opioid-overdose is the leading cause of death among this population, with the initial weeks following release proving especially fatal. Extended-release naltrexone...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Sean M., Jeng, Philip J., Poole, Sabrina A., Jalali, Ali, Vocci, Frank J., Gordon, Michael S., Woody, George E., Polsky, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178627/
https://www.ncbi.nlm.nih.gov/pubmed/32321570
http://dx.doi.org/10.1186/s13722-020-00188-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178627/
https://www.ncbi.nlm.nih.gov/pubmed/32321570
http://dx.doi.org/10.1186/s13722-020-00188-5

Ejemplares similares